BioCryst Pharmaceuticals Inc (BCRX)

NASDAQ · Biotechnology

10.07
+0.37 (+3.81%)
Updated Aug 19, 9:42 PM ET
AI Rating
Buy
Overall Score
64
Trend
68
Momentum
72
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

BioCryst Pharmaceuticals Inc is trading at $10.07, up 3.81% on the session. The 50 day average sits at $9.46 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 52.2, which reads as neutral, and MACD is bullish crossover. Volume is above average.

The nearest support is around $8.95 with resistance near $9.91, so that band frames the current range. Average daily movement is roughly $0.51, or about 5.0% of the share price, which is what any stop placement has to allow for. The overall health score of 64 out of 100 combines a trend score of 68, momentum of 72 and a risk score of 46.

Technical indicators

RSI (14)
52.2
neutral
MACD
0.114
bullish crossover
SMA 20
9.49
SMA 50
9.46
SMA 200
--
unknown
ATR (14)
0.51
avg daily range
Support
8.95
Resistance
9.91
Volume vs 20d
1.15x
above average
Volatility
48.5%
annualised
1 month
+6.92%
3 months
+1.78%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.